Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tanswell

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
European Journal of Clinical Pharmacology|January 1, 1989
Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunctionB Krakamp, P Tanswell, H Vogel, et al.
The Biochemical Journal|May 1, 1990
Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinaseJ Krause, W Seydel, G Heinzel, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Pharmacokinetic-pharmacodynamic and metabolite modeling with TopFitP Tanswell, G Heinzel, H Weisenberger, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liverP Tanswell, G Heinzel, A Greischel, et al.
FEBS Letters|November 1, 1974
Inhibition of yeast phosphoglycerate kinase by lanthanide-ATP complexesP Tanswell, E W Westhead, R J Williams
Thrombosis and Haemostasis|June 30, 1979
Immunological approaches to the structure of fibrinogenP Tanswell, R Gollwitzer, H Stan-Lotter, et al.
Immunochemistry|April 1, 1977
Immunochemistry of bovine fibrinogen--III. Localization of two antigenic determinants in fibrinopeptide BP Tanswell, H Stan-Lotter, R Gollwitzer, et al.
Thrombosis and Haemostasis|June 30, 1989
Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarctionE Seifried, P Tanswell, D Ellbrück, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepineW Londong, V Londong, C Federle, et al.
European Journal of Biochemistry|September 1, 1975
Quantitative determination of the conformation of ATP in aqueous solution using the lanthanide cations as nuclear-magnetic-resonance probesP Tanswell, J M Thornton, A V Korda, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
European Journal of Clinical Pharmacology|January 1, 1989
Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunctionB Krakamp, P Tanswell, H Vogel, et al.
The Biochemical Journal|May 1, 1990
Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinaseJ Krause, W Seydel, G Heinzel, et al.
International Journal of Clinical Pharmacology and Therapeutics|October 1, 1995
Pharmacokinetic-pharmacodynamic and metabolite modeling with TopFitP Tanswell, G Heinzel, H Weisenberger, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1990
Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liverP Tanswell, G Heinzel, A Greischel, et al.
FEBS Letters|November 1, 1974
Inhibition of yeast phosphoglycerate kinase by lanthanide-ATP complexesP Tanswell, E W Westhead, R J Williams
Thrombosis and Haemostasis|June 30, 1979
Immunological approaches to the structure of fibrinogenP Tanswell, R Gollwitzer, H Stan-Lotter, et al.
Immunochemistry|April 1, 1977
Immunochemistry of bovine fibrinogen--III. Localization of two antigenic determinants in fibrinopeptide BP Tanswell, H Stan-Lotter, R Gollwitzer, et al.
Thrombosis and Haemostasis|June 30, 1989
Pharmacokinetics and haemostatic status during consecutive infusions of recombinant tissue-type plasminogen activator in patients with acute myocardial infarctionE Seifried, P Tanswell, D Ellbrück, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepineW Londong, V Londong, C Federle, et al.
European Journal of Biochemistry|September 1, 1975
Quantitative determination of the conformation of ATP in aqueous solution using the lanthanide cations as nuclear-magnetic-resonance probesP Tanswell, J M Thornton, A V Korda, et al.
Pageof 4